Apixaban in Patients with Atrial Fibrillation

Connolly, Stuart J., Eikelboom, John, Joyner, Campbell, Diener, Hans-Christoph, Hart, Robert, Golitsyn, Sergey, Flaker, Greg, Avezum, Alvaro, Hohnloser, Stefan H., Diaz, Rafael, Talajic, Mario, Zhu, Jun, Pais, Prem, Budaj, Andrzej, Parkhomenko, Alexander, Jansky, Petr, Commerford, Patrick, Tan, Ru San, Sim, Kui-Hian, Lewis, Basil S., Van Mieghem, Walter, Lip, Gregory Y.H., Kim, Jae Hyung, Lanas-Zanetti, Fernando, Gonzalez-Hermosillo, Antonio, Dans, Antonio L., Munawar, Muhammad, O'Donnell, Martin, Lawrence, John, Lewis, Gayle, Afzal, Rizwan, Yusuf, Salim·2011·New England Journal of Medicine
DOI 10.1056/nejmoa1007432

Cited by (1,002)

Items 601–700 of 1,002

  1. Interindividual Variability of Apixaban Plasma Concentrations: Influence of Clinical and Genetic Factors in a Real-Life Cohort of Atrial Fibrillation Patients
    Adela-Nicoleta Roşian, Ştefan Horia Roşian, Bela Kiss, Maria-Georgia Ștefan, Adrian Pavel Trifa, Camelia Ober, Ovidiu Anchidin, Anca Dana Buzoianu · 2020 · Genes
  2. Prophylaxis and treatment of venous thromboembolism in the critically ill
    Sarah M. Adriance, Claire V. Murphy · 2013 · International Journal of Critical Illness and Injury Science
  3. Prevention of stroke and systemic embolism with rivaroxaban compared with warfarin in Chinese patients with atrial fibrillation
    Lizheng Mao, Chengyan Li, Tao Li, Kunxiong Yuan · 2013 · Vascular
  4. Vitamin K Antagonists–Associated Cerebral Hemorrhages
    Nelly Dequatre‐Ponchelle, Hilde Hénon, Marta Pasquini, Matthieu Pierre Rutgers, Régis Bordet, Didier Leys, Charlotte Cordonnier · 2013 · Stroke
  5. Anticoagulation Therapy in Traumatic Brain Injury
    Tomasz Tykocki, Krystyna Guzek · 2016 · World Neurosurgery
  6. Comparative efficacy and safety of warfarin care bundles and novel oral anticoagulants in patients with atrial fibrillation: a systematic review and network meta-analysis
    Siok Shen Ng, Nai Ming Lai, Surakit Nathisuwan, Nowrozy Kamar Jahan, Piyameth Dilokthornsakul, Khachen Kongpakwattana, William Hollingworth, Nathorn Chaiyakunapruk · 2020 · Scientific Reports
  7. Thromboembolism in Older Adults
    Peter L. Gross, Noel Chan · 2021 · Frontiers in Medicine
  8. Anticoagulation in Patients With Device‐Detected Atrial Fibrillation With and Without a Prior Stroke or Transient Ischemic Attack: The NOAH‐AFNET 6 Trial
    Hans‐Christoph Diener, Nina Becher, Susanne Sehner, Tobias Toennis, Emanuele Bertaglia, Carina Blomström‐Lundqvist, Axel Brandes, Vincent Beuger, Melanie Calvert, A. John Camm et al. · 2024 · Journal of the American Heart Association
  9. Ablation of atrial fibrillation and risk of stroke: A meta-analysis
    Rui Andre Providencia, Hussam Ali, Sérgio Barra, António Creta, Kishore Kukendrarajah, Prapa Kanagaratnam, Michał M. Farkowski, Riccardo Cappato · 2025 · Heart Rhythm
  10. Newer Anticoagulants in Cardiovascular Disease
    Abhishek Maan, Ram Padmanabhan, Amir Y. Shaikh, Moussa Mansour, Jeremy Neil Ruskin, Edwin Kevin Heist · 2012 · Cardiology in Review
  11. New anticoagulants
    Lisa Baumann Kreuziger, Colleen T. Morton, David J. Dries · 2012 · The Journal of Trauma: Injury, Infection, and Critical Care
  12. Cost-effectiveness of Apixaban versus Warfarin and Aspirin in Sweden for Stroke Prevention in Patients with Atrial Fibrillation
    Tereza Lanitis, Thitima Kongnakorn, Lena Jacobson, Anna De Geer · 2014 · Thrombosis Research
  13. Intersection of cardiovascular disease and kidney disease
    Nisha Bansal, Chi‐yuan Hsu, Alan S. Go · 2014 · Current Opinion in Nephrology & Hypertension
  14. Stroke Prevention in Atrial Fibrillation: Focus on Latin America
    Ayrton Roberto Massaro, Gregory Y.H. Lip · 2016 · Arquivos Brasileiros de Cardiologia
  15. Anticoagulation in atrial fibrillation with heart failure
    Lei Zhao, William Y.S. Wang, Xinchun Yang · 2018 · Heart Failure Reviews
  16. Atrial fibrillation and stroke: a practical guide
    Jonathan G. Best, Robert Bell, Mohammad Mahfuzul Haque, Arvind Chandratheva, David John Werring · 2019 · Practical Neurology
  17. Low Dose of Direct Oral Anticoagulants after Left Atrial Appendage Occlusion
    Pedro Luis Cepas Guillén, Eduardo Flores‐Umanzor, Ander Regueiro, Salvatore Brugaletta, Cristina Ibáñez, Laura Sanchís, Marta Sitges, Josep Rodés‐Cabau, Manel Sabaté, Xavier Freixa · 2021 · Journal of Cardiovascular Development and Disease
  18. The Pharmacology and Therapeutic Use of Dabigatran Etexilate
    Sarah A. Spinler · 2012 · The Journal of Clinical Pharmacology
  19. Anticoagulant therapy for patients with ischaemic stroke
    Graeme J. Hankey · 2012 · Nature Reviews Neurology
  20. Bleeding of New Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation: A Meta-Analysis of Randomized Controlled Trials
    Joey SW Kwong, Yat‐Yin Lam, Bryan P. Yan, Cheuk‐Man Yu · 2012 · Cardiovascular Drugs and Therapy
  21. New anticoagulant drugs for treatment of venous thromboembolism and stroke prevention in atrial fibrillation
    Armando Tripodi, Gualtiero Palareti · 2012 · Journal of Internal Medicine
  22. Characteristics of Symptomatic Intracranial Hemorrhage in Patients Receiving Non-Vitamin K Antagonist Oral Anticoagulant Therapy
    Hisanao Akiyama, Kenji Uchino, Yasuhiro Hasegawa · 2015 · PLoS ONE
  23. Warfarin-related nephropathy: another newly recognized complication of an old drug
    Dana V. Rizk, David G. Warnock · 2011 · Kidney International
  24. Recommendations for thromboprophylaxis in the 2012 focused update of the ESC guidelines on atrial fibrillation: a commentary
    Gregory Y.H. Lip · 2013 · Journal of Thrombosis and Haemostasis
  25. Patent Foramen Ovale and Cryptogenic Stroke
    Anthony J. Furlan, Marek Jauss · 2013 · Stroke
  26. Can TAVI patients receive aspirin monotherapy as patients after surgical aortic bioprosthesis implantation? Data from the Polish Registry — POL-TAVI
    Katarzyna Czerwińska, Marian Zembala, Maciej Dąbrowski, Adam Witkowski, Andrzej J. Ochala, Janusz Kochman, Dariusz Dudek, Piotr Kübler, Dariusz Jagielak, Janina Stępińska · 2016 · International Journal of Cardiology
  27. Direct Oral Anticoagulants and Medical Comorbidities in Patients Needing Dental Extractions: Management of the Risk of Bleeding
    Nadia Cocero, Michele Basso, Simona Grosso, Stefano Carossa · 2018 · Journal of Oral and Maxillofacial Surgery
  28. Use of direct oral anticoagulants in the treatment of left ventricular thrombi: A tertiary center experience and review of the literature
    Mohamed Shokr, Abdelrahman Ahmed, Hossam Abubakar, Ziad SayedAhmad, Ahmed Rashed, Luis Afonso, Shaun J. Cardozo · 2018 · Clinical Case Reports
  29. Atrial fibrillation in the cardiometabolic patient
    Francesco De Sensi, Sarah Costantino, Ugo Limbruno, Francesco Paneni · 2019 · Minerva Medica
  30. Four‐year incidence of major adverse cardiovascular events in patients with atherosclerosis and atrial fibrillation
    Benjamin Miao, A. V. Hernández, Y. Roman, M. Alberts, C. Coleman, W. Baker · 2020 · Clinical Cardiology
  31. Left atrial appendage occlusion vs novel oral anticoagulation for stroke prevention in atrial fibrillation: rationale and design of the multicenter randomized occlusion-AF trial
    Kasper Korsholm, Dorte Damgaard, Jan Brink Valentin, Erik Jerome Stene Packer, Jacob Odenstedt, Juha P. Sinisalo, Jukka Putaala A, Halvor Næss, Mohammad Ahmad Al-Jazi, Jan‐Erik Karlsson et al. · 2021 · American Heart Journal
  32. A Decision Analysis of Percutaneous Left Atrial Appendage Occlusion Relative to Novel and Traditional Oral Anticoagulation for Stroke Prevention in Patients with New-Onset Atrial Fibrillation
    Andrew Micieli, Harindra Channa Wijeysundera, Feng Qiu, Clare L. Atzema, Sheldon M. Singh · 2015 · Medical Decision Making
  33. Atrial Fibrillation and Quality of Life Related to Disease and Treatment: Focus On Anticoagulation
    Fernando Arribas, Rafaél Peinado, José Miguel Ormaetxe Merodio · 2014 · Future Cardiology
  34. Revisão sistemática das análises custo‐efetividade dos novos anticoagulantes orais na prevenção do acidente vascular cerebral na fibrilhação auricular
    João Ferreira, Ana Mirco · 2015 · Revista Portuguesa de Cardiologia
  35. Cardiovascular Management in Asymptomatic (Silent) Cerebral Microbleeds and Suspected Cerebral Amyloid Angiopathy
    Andreas Charidimou, Eric Edward Smith · 2024 · Stroke
  36. Risk of Intracranial Hemorrhage Associated With Direct Oral Anticoagulation vs Antiplatelet Therapy
    Mark Coyle, Amy Lynch, Meave Higgins, Maria M. Costello, Conor S. Judge, Martin James O'Donnell, Catriona Reddin · 2024 · JAMA Network Open
  37. Antithrombotic treatment for stroke prevention in atrial fibrillation: The Asian agenda
    Chen-Huan Chen, Mien‐Cheng Chen, Harry H. Gibbs, Sun Uck Kwon, Sidney T. Lo, Young Keun On, Azhari Rosman, Nijasri Charnnarong Suwanwela, Ru‐San Tan, Louie S. Tirador et al. · 2015 · International Journal of Cardiology
  38. Treatment with novel oral anticoagulants
    Shari Ghanny, Mark Andrew Crowther · 2013 · Current Opinion in Hematology
  39. A New Landscape for Stroke Prevention in Atrial Fibrillation
    Amitava Banerjee, Francisco R. Marín, Gregory Y.H. Lip · 2011 · Stroke
  40. Practical aspects of the oral new anticoagulants
    Thomas G. DeLoughery · 2011 · American Journal of Hematology
  41. An Updated Review of Target‐Specific Oral Anticoagulants Used in Stroke Prevention in Atrial Fibrillation, Venous Thromboembolic Disease, and Acute Coronary Syndromes
    Christina L. Cove, Elaine M. Hylek · 2013 · Journal of the American Heart Association
  42. Measurement of Anti-Factor Xa Activity in Patients on Apixaban for Non-Valvular Atrial Fibrillation
    Hiroyuki Osanai, Masayoshi Ajioka, Tomohiro Masutomi, Tasuku Kuwayama, Sota Ishihama, Yusuke Sakamato, Naoya Otaka, Teruhiro Sakaguchi, Yosuke Inoue, Takahiro Kanbara et al. · 2015 · Circulation Journal
  43. Association of Intracranial Hemorrhage Risk With Non–Vitamin K Antagonist Oral Anticoagulant Use vs Aspirin Use
    Wen‐Yi Huang, Daniel E. Singer, Yi‐Ling Wu, Chern‐En Chiang, Hsu‐Huei Weng, Meng Lee, Bruce I Ovbiagele · 2018 · JAMA Neurology
  44. The Clinical Dilemma of Anticoagulation Use in Patients with Cerebral Amyloid Angiopathy and Atrial Fibrillation
    Rocco J. Cannistraro, James Frederick Meschia · 2018 · Current Cardiology Reports
  45. Patients aged 90 years or older with atrial fibrillation treated with oral anticoagulants: A multicentre observational study
    Michela Giustozzi, Maria Cristina Vedovati, Melina Verso, Luca Scrucca, Serenella Conti, Paolo Verdecchia, Giulio Bogliari, Lucia Pierpaoli, Giancarlo Agnelli, Cecilia Becattini · 2019 · International Journal of Cardiology
  46. Direct Oral Anticoagulants and Bleeding Risk (in Comparison to Vitamin K Antagonists and Heparins), and the Treatment of Bleeding
    Gualtiero Palareti · 2014 · Seminars in Hematology
  47. Assessment of Patient Adherence to Direct Oral Anticoagulant vs Warfarin Therapy
    Salma Imran Patel, Chad Christian Cherington, Robyn Marie Scherber, Kathryn Barr, Ryan Y. McLemore, Donald Edward Morisky, Stephen Cha, Farouk Mookadam, Fadi Elias Shamoun · 2017 · Journal of Osteopathic Medicine
  48. The left atrial appendage exclusion for prophylactic stroke reduction (LEAAPS) trial: Rationale and design
    Richard Paul Whitlock, Patrick M. McCarthy, Marc Gerdisch, Basel Ramlawi, John Hunter Alexander, Ibrahim Sultan, David Z. Rose, Jeff S. Healey, Yashasvi Awasthi, Emilie P. Belley‐Côté et al. · 2024 · American Heart Journal
  49. Cost-effectiveness of new oral anticoagulants in the prevention of stroke in patients with atrial fibrillation
    Anuraag R. Kansal, Ying Zheng, Tiffany Pokora, Sonja V. Sorensen · 2013 · Best Practice & Research Clinical Haematology
  50. Oral Anticoagulants and Status of Antidotes for the Reversal of Bleeding Risk
    Joseph Ebright, Shaker A. Mousa · 2014 · Clinical and Applied Thrombosis/Hemostasis
  51. Uninterrupted New Oral Anticoagulants Compared With Uninterrupted Vitamin K Antagonists in Ablation of Atrial Fibrillation: A Meta-analysis
    Ramez S. Nairooz, Karam F. Ayoub, Partha Sardar, Jason J. Payne, Ahmed A. Almomani, Naga Venkata K. Pothineni, Fnu Shailesh, Wilbert S. Aronow, Debabrata Mukherjee · 2015 · Canadian Journal of Cardiology
  52. Factor Xa inhibitors: a novel therapeutic class for the treatment of nonvalvular atrial fibrillation
    Delilah J. McCarty, April M. Robinson · 2015 · Therapeutic Advances in Cardiovascular Disease
  53. Defining nonvalvular atrial fibrillation: A quest for clarification
    Raphaël Pedro Martins, Vincent Galand, Edouard Colette, Nathalie Béhar, Dominique Pavin, Christophe Leclercq, Jean‐Claude Daubert, Philippe Mabo · 2016 · American Heart Journal
  54. Advances in Stroke 2017
    Julie A Bernhardt, Richard David Zorowitz, Kyra J. Becker, E. Keller, Gustavo Saposnik, Daniel Strbian, Martin Dichgans, Daniel Woo, Mathew J. Reeves, Amanda Gay Thrift et al. · 2018 · Stroke
  55. Cost-effectiveness of rivaroxaban and aspirin compared to aspirin alone in patients with stable cardiovascular disease: An Australian perspective
    Zanfina Ademi, Ella Zomer, Andrew Maxwell Tonkin, Danny Liew · 2018 · International Journal of Cardiology
  56. Fifty years of research on antithrombotic therapy: Achievements and disappointments
    Jack Hirsh, John W. Eikelboom, Noel Chan · 2019 · European Journal of Internal Medicine
  57. Therapeutic Drug Monitoring of Direct Oral Anticoagulants May Increase Their Benefit-Risk Ratio
    Marjorie Bernier, Sarah-Line Lancrerot, Nadège Parassol, Thibaud Lavrut, Julien Viotti, Fanny Rocher, Milou‐Daniel Drici · 2020 · Journal of Cardiovascular Pharmacology
  58. Data‐driven machine‐learning analysis of potential embolic sources in embolic stroke of undetermined source
    George Ntaios, S. F. Weng, Kalliopi Perlepe, Ralph Kwame Akyea, Laura A. Condon, Dimitris Lambrou, Gaia Sirimarco, Davide Strambo, Ashraf Eskandari, Efstathia Karagkiozi et al. · 2020 · European Journal of Neurology
  59. Guía ESC 2020 sobre el diagnóstico y tratamiento de la fibrilación auricular, desarrollada en colaboración de la European Association of Cardio-Thoracic Surgery (EACTS)
    Gerhard Hindricks, Tatjana Potpara, Nikolaos Dagres, Elena Arbelo, Jeroen Joost Bax, Carina Blomström‐Lundqvist, Giuseppe Boriani, Manuel Castellà, Gheorghe‐Andrei Dan, Polychronis Dilaveris et al. · 2021 · Revista Española de Cardiología
  60. Atherosclerotic Burden and Vascular Risk in Stroke Patients With Atrial Fibrillation
    Jong‐Ho Park, Jong‐Won Chung, Oh Young Bang, Gyeong‐Moon Kim, Kang‐Ho Choi, Man‐Seok Park, Joon‐Tae Kim, Yang‐Ha Hwang, Tae‐Jin Song, Yong‐Jae Kim et al. · 2021 · Stroke
  61. Guía ESC 2020 sobre el diagnóstico y tratamiento del síndrome coronario agudo sin elevación del segmento ST
    Jean‐Philippe Collet, Hölger Thiele, Emanuele Barbato, Olivier Barthélémy, Johann K Bauersachs, Deepak L. Bhatt, Paul Dendale, Maria Dorobanţu, Thor Edvardsen, Thierry A Folliguet et al. · 2021 · Revista Española de Cardiología
  62. Percutaneous Left Atrial Appendage Occlusion in Comparison to Non‐Vitamin K Antagonist Oral Anticoagulant Among Patients With Atrial Fibrillation
    Peter A. Noseworthy, Holly K. Van Houten, Harlan M. Krumholz, David M. Kent, Neena S. Abraham, Jonathan Graff‐Radford, Mohamad Adnan Alkhouli, Henry J. Henk, Nilay D. Shah, Bernard John Gersh et al. · 2022 · Journal of the American Heart Association
  63. Hemostasis and Alterations of the Central Nervous System
    G. D. del Zoppo, Yoshikane Izawa, B. Hawkins · 2013 · Seminars in Thrombosis and Hemostasis
  64. Análisis coste-efectividad de apixabán frente a acenocumarol en la prevención del ictus en pacientes con fibrilación auricular no valvular en España
    Gonzalo Barón‐Esquivias, Ginés Escolar, José Luis Zamorano, Lourdes Betegón Nicolás, Cristina Canal Fontcuberta, Marina de Salas-Cansado, Darío Rubio-Rodríguez, Carlos Rubio‐Terres · 2014 · Revista Española de Cardiología
  65. Net Clinical Benefit of Oral Anticoagulants: A Multiple Criteria Decision Analysis
    Jason C. Hsu, Cheng‐Yang Hsieh, Yea‐Huei Kao Yang, Christine Y. Lu · 2015 · PLoS ONE
  66. Modification of Outcomes With Aspirin or Apixaban in Relation to CHADS 2 and CHA 2 DS 2 -VASc Scores in Patients With Atrial Fibrillation
    Gregory Y.H. Lip, Stuart J. Connolly, Salim Yusuf, Olga Shestakovska, Greg Flaker, Robert G. Hart, Fernando Tomas Lanas, Denis Xavier, John W. Eikelboom · 2013 · Circulation Arrhythmia and Electrophysiology
  67. Early Canadian Multicenter Experience With WATCHMAN for Percutaneous Left Atrial Appendage Closure
    Jacqueline Saw, Peter Fahmy, Lorenzo Azzalini, Jean-François Marquis, Benjamin M. Hibbert, Carlos Arturo Morillo, Aldo G. Carrizo, Réda Ibrahim · 2017 · Journal of Cardiovascular Electrophysiology
  68. Prevention and management of stroke in women
    Matthew D. Howe, Louise D. McCullough · 2015 · Expert Review of Cardiovascular Therapy
  69. Cognitive Function: Is There More to Anticoagulation in Atrial Fibrillation Than Stroke?
    Lin Sen Cao, Sean D. Pokorney, Kathleen M. Hayden, Kathleen Anne Welsh-Bohmer, Laura Kristin Newby · 2015 · Journal of the American Heart Association
  70. Nuevas evidencias, nuevas controversias: análisis crítico de la guía de práctica clínica sobre fibrilación auricular 2010 de la Sociedad Europea de Cardiología
    Manuel P. Anguita, Fernando Worner, Pere Domenech, Francisco R. Marín, Javier Ortigosa, Julián Pérez‐Villacastín, Antonio Fernández‐Ortíz, Ángel Alonso, Angel R. Cequier, Josep Comin Colet et al. · 2011 · Revista Española de Cardiología
  71. Use of novel oral anticoagulants for patients with atrial fibrillation: Systematic review and clinical implications
    Nancy M. Albert · 2013 · Heart & Lung
  72. Systemic, noncerebral, arterial embolism in 21,105 patients with atrial fibrillation randomized to edoxaban or warfarin: Results from the Effective Anticoagulation With Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis in Myocardial Infarction Study 48 trial
    Bram J. Geller, Robert Patrick Giugliano, Eugene Braunwald, Sabina A. Murphy, JAMES J. HANYOK, Jianqing Jin, Michele F. Mercuri, Elliott Marshall Antman, Christian Thomas Ruff · 2015 · American Heart Journal
  73. Revista Española de Geriatría y Gerontología
    Rocío Plaza Santos, Consuelo Froilán Torres, María Dolores Martín‐Arranz, José Manuel Suárez de Parga, Mercedes Aldeguer Martínez · 2016
  74. Inadequate stroke prevention in Korean atrial fibrillation patients in the post-warfarin era
    Eun Joo Choi, Iyn‐Hyang Lee, Nam Kyung Je · 2016 · International Journal of Cardiology
  75. Use of Oral Anticoagulation in the Management of Atrial Fibrillation in Patients with ESRD: Pro
    Peter Andrew McCullough, Timothy N. Ball, Katy Mathews Cox, Manish D. Assar · 2016 · Clinical Journal of the American Society of Nephrology
  76. Percutaneous left atrial appendage closure is not ready for routine clinical use
    John M. Mandrola, Andrew Foy, Gerald V. Naccarelli · 2017 · Heart Rhythm
  77. Percutaneous Left Atrial Appendage Occlusion for the Prevention of Stroke in Patients with Atrial Fibrillation: Review and Critical Appraisal
    Peter Dieter Schellinger, Georgios K. Tsivgoulis, Thorsten Steiner, Martin Köhrmann · 2018 · Journal of Stroke
  78. Valvular and Nonvalvular Atrial Fibrillation in Patients Undergoing Transcatheter Aortic Valve Replacement
    Taishi Okuno, Daniel Hagemeyer, Nicolas Brugger, Christoph P. Ryffel, Dik Heg, Jonas Lanz, Fabien Praz, Stefan Stortecky, Lorenz Räber, Laurent Roten et al. · 2020 · JACC: Cardiovascular Interventions
  79. Cost–effectiveness of an insertable cardiac monitor to detect atrial fibrillation in patients with cryptogenic stroke
    L. Sawyer, Klaus Karl Witte, Matthew R. Reynolds, Suneet Mittal, Frank Grimsey Jones, Sarah C. Rosemas, Paul Ziegler, Rachelle Elizabeth Kaplon, Shadi R. Yaghi · 2020 · Journal of Comparative Effectiveness Research
  80. Why is warfarin underused for stroke prevention in atrial fibrillation? A detailed review of electronic medical records
    Marc B. Rosenman, Layla B. Baker, Yonghua Jing, Dinara Makenbaeva, Brian L. Meissner, Teresa A. Simon, Daniel Wiederkehr, Steve Deitelzweig · 2012 · Current Medical Research and Opinion
  81. The new oral anticoagulants in atrial fibrillation: Once daily or twice daily?
    Giulia Renda, Raffaele De Caterina · 2013 · Vascular Pharmacology
  82. Pharmacotherapy in Medicare beneficiaries with atrial fibrillation
    Jonathan Paul Piccini, Xiaojuan Mi, Tracy A. DeWald, Alan S. Go, Adrian F. Hernandez, Lesley H. Curtis · 2012 · Heart Rhythm
  83. Stroke and Systemic Embolism Prevention in Patients with Atrial Fibrillation in Belgium: Comparative Cost Effectiveness of New Oral Anticoagulants and Warfarin
    Thitima Kongnakorn, Tereza Lanitis, Lieven Annemans, Vincent Thijs, Marnix Goethals, Sophie Marbaix, Jean-Claude Wautrecht · 2014 · Clinical Drug Investigation
  84. Manejo de los anticoagulantes orales de acción directa en el período perioperatorio y técnicas invasivas
    Juan V. Llau, Raquel Ferrandis, J. Castillo, J. de Andrés, Carmen Guiralt Gomar, A. Gómez‐Luque, F. Hidalgo, Luis Miguel Torres · 2012 · Revista Española de Anestesiología y Reanimación
  85. Cost-Effectiveness of Left Atrial Appendage Closure for Stroke Prevention in Atrial Fibrillation Patients With Contraindications to Anticoagulation
    Jacqueline Saw, Maria C. Bennell, Sheldon M. Singh, Harindra Channa Wijeysundera · 2016 · Canadian Journal of Cardiology
  86. Pharmacist prescribing within an integrated health system in Washington
    Roger A. Woolf, Amanda Locke, Catherine Potts · 2016 · American Journal of Health-System Pharmacy
  87. Shifting to a non-vitamin K antagonist oral anticoagulation agent from vitamin K antagonist in atrial fibrillation
    Emil Loldrup Fosbøl, Naja Emborg Vinding, Morten Lamberts, Laila Stærk, Anna Gundlund, Kasper Gadsbøll, Lars Køber, Gunnar Gislason, Jonas Bjerring Olesen · 2017 · EP Europace
  88. Left atrial appendage closure for prevention of death, stroke, and bleeding in patients with nonvalvular atrial fibrillation
    Steffen Gloekler, Jacqueline Saw, Konstantinos C. Koskinas, Caroline Kleinecke, Werner Jung, Fabian Nietlispach, Bernhard Meier · 2017 · International Journal of Cardiology
  89. More light at the end of the tunnel – apixaban in atrial fibrillation
    Sheila Anne Doggrell · 2012 · Expert Opinion on Investigational Drugs
  90. New Avenues for Anticoagulation in Atrial Fibrillation
    Simon H Mantha, Katherine P. Cabral, Jack Ansell · 2012 · Clinical Pharmacology & Therapeutics
  91. Battle of oral anticoagulants in the field of atrial fibrillation scrutinized from a clinical practice (the real world) perspective
    Raúl Altman, Hector O Vidal · 2011 · Thrombosis Journal
  92. North American Thrombosis Forum, AF Action Initiative Consensus Document
    Christian Thomas Ruff, Jack Ansell, Richard Clinton Becker, Emelia J. Benjamin, David J. Deicicchi, N.A. Mark Estes, Michael D. Ezekowitz, John R. Fanikos, Jawed Fareed, David A. Garcia et al. · 2016 · The American Journal of Medicine
  93. Bleeding in patients receiving non-vitamin K oral anticoagulants: clinical trial evidence
    Arthur Bracey, Wassim Shatila, James M. Wilson · 2018 · Therapeutic Advances in Cardiovascular Disease
  94. Safety of apixaban compared to warfarin in hemodialysis patients: Do antiplatelets make a difference?
    Filip Ionescu, Christopher J. Cooper, Ioana Petrescu, Julie George, Saima Mansuri · 2021 · European Journal Of Haematology
  95. Antiplatelet therapy in patients with atrial fibrillation: a systematic review and meta-analysis of randomized trials
    Alexander Philipp Benz, Isabelle Johansson, Willem J.M. Dewilde, Renato D. Lópes, Roxana Mehran, Samantha Sartori, Nikolaus Sarafoff, Satoshi Yasuda, William F McIntyre, Jeff S. Healey et al. · 2021 · European Heart Journal - Cardiovascular Pharmacotherapy
  96. Hybrid feature fusion for classification optimization of short ECG segment in IoT based intelligent healthcare system
    Xianbin Zhang, Mingzhe Jiang, Wanqing Wu, Victor Hugo C. de Albuquerque · 2021 · Neural Computing and Applications
  97. Atrial fibrillation: primary prevention, secondary prevention, and prevention of thromboembolic complications: part 1
    Richard G. Trohman, Henry Darchon Huang, Parikshit S. Sharma · 2023 · Frontiers in Cardiovascular Medicine
  98. Development of apixaban: a novel anticoagulant for prevention of stroke in patients with atrial fibrillation
    Michael S. Hanna, Puneet Mohan, Robert M. Knabb, Elora Gupta, Charles E. Frost, John H. Lawrence · 2014 · Annals of the New York Academy of Sciences
  99. Novel anticoagulants and antiplatelet agents; a guide for the urologist
    Gidon Ellis, Alan John Camm, Soumendra Nath Datta · 2015 · British Journal of Urology
  100. Incidence, Mortality, and Risk Factors for Oral Anticoagulant–associated Intracranial Hemorrhage in Patients with Atrial Fibrillation
    Rebbeca A. Grysiewicz, Philip B. Gorelick · 2014 · Journal of Stroke and Cerebrovascular Diseases